You are here: Industry Insights > recall

News List

Altaire Issues Recall of Multiple Ophthalmic Products Sold at Walgreens americanpharmaceuticalreview
July 08, 2019
Altaire Pharmaceuticals is voluntarily recalling the Over-the-Counter (OTC) drug products and lots, within expiry, sold at Walgreens.
Macleods Pharmaceuticals issues recall due to NMBA impurities europeanpharmaceuticalreview
July 05, 2019
Macleods has issued a recall of 32 lots of drug products that contained trace amounts of NMBA impurities.
Fresenius Kabi Issues Recall of Two Lots of Fluorouracil Injection americanpharmaceuticalreview
July 04, 2019
Fresenius Kabi is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.
Infusion Options Issues Recall of All Lots of All Sterile Products Due to Lack of Sterility Assurance americanpharmaceuticalreview
June 26, 2019
Infusion Options is voluntarily recalling all lots of all sterile products within expiry to the hospital level. These products are being recalled due to a lack of assurance of sterility.
Thanks for the Stinky Memories: Scientists Say Bad Smells Boost Recall drugs
June 25, 2019
Bad smells, better memory?
RXQ Compounding Issues Recall of All Sterile Products within Expiry June 21, 2019
RXQ Compounding is voluntarily recalling all sterile human and animal products within expiry to the user level due to lack of sterility process assurance associated with the production of the Company’s sterile products. In addition, RXQ is voluntarily cea
Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance drugs
June 10, 2019
Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance.
Heritage Pharmaceuticals Issues Recall of Amikacin Sulfate Injection, Prochlorperazine Edisylate Injection americanpharmaceuticalreview
May 30, 2019
Heritage Pharmaceuticals is initiating a voluntary recall of Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), Lot: VEAC025, Expiry Date: October 2019 and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL) ...
Par Pharmaceutical Issues Recall of One Lot of Mycophenolate Mofetil for Injection americanpharmaceuticalreview
May 08, 2019
Endo International announced one of its operating companies, Par Pharmaceutical, is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level.
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance fda
May 05, 2019
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance

Previous page 1 2 3 4 5 6 7 8 Next page